SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-120275
Filing Date
2016-05-12
Accepted
2016-05-12 08:21:44
Documents
3
Period of Report
2016-05-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-11074_38k.htm 8-K 34473
2 EX-99.1 a16-11074_3ex99d1.htm EX-99.1 17472
3 GRAPHIC g110743mmi001.jpg GRAPHIC 4442
  Complete submission text file 0001104659-16-120275.txt   59417
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34921 | Film No.: 161641720
SIC: 2834 Pharmaceutical Preparations